Manufacturing
Valuation Multiples

Start By Checking Whether the Number You Read Is Even About Manufacturing

We rebuilt this section after fetching every source behind it. The honest result is a correction rather than a confirmation.

Two figures dominate the search results for manufacturing multiples: a GF Data range of roughly 6x to 10x, and a Capstone Partners figure of 11.1x said to be climbing. The pair gets presented as a puzzle about buyer types, financial sponsors on the low end and strategic acquirers on the high end. The buyer-type insight is sound. Nearly every number attached to it is wrong.

What GF Data Actually Publishes

Go to the source. GF Data's own Q3 2025 release states that average purchase price multiples rose to 7.5x trailing 12-month adjusted EBITDA, on 66 completed transactions in the quarter and 211 year to date. The Q4 release distributed through ACG reports that for the full year, average purchase price multiples held steady year over year at 7.2x trailing twelve-month adjusted EBITDA across 297 completed transactions, a 23% decline in volume from 2024, covering private-equity-sponsored transactions in the $10 million to $500 million enterprise value range.

Neither release breaks multiples out by industry. ACG's notes that the full reports include detailed drilldowns into valuations by deal size, buyer type, and industry, and that those reports are available exclusively to GF Data subscribers. There is therefore no free, citable GF Data manufacturing multiple. The ladder in wide circulation, 5.9x at $10 million to $25 million of enterprise value rising to 10.0x at $100 million to $250 million, reaches the public through CapitalPad's restatement. Its 211-transaction count matches GF Data's own year-to-date figure exactly, which is reassuring about provenance, but the band breakdown appears in no GF Data release we could reach. Treat that ladder as a secondary restatement rather than something anyone has verified at source, and note the period: it is year to date through September 30, 2025.

What Capstone Actually Publishes

The 11.1x is the bigger problem, because Capstone does publish industrials data and the published data says something close to the opposite.

Capstone's Annual Industrials M&A Report puts industrials at 8.9x in 2025, down from 9.3x in 2024 and marking a continued compression from the 2022 peak of 11.4x, measured against a 2018 to 2025 historical average of 10.2x.

Now compare that to the claim in circulation, which is that manufacturing rose to 11.1x from 10.2x. Capstone's own figures show industrials falling to 8.9x from 9.3x. The 10.2x is not a prior-year reading at all; it is the eight-year average. The nearest thing to 11.1x anywhere in the report is 11.4x, the 2022 peak the market has been compressing away from ever since. So the widely repeated claim is not simply unsourced. It inverts the direction of travel and repurposes a long-run average as a starting point.

The same report supplies, properly sourced, the buyer-population fact the original framing was groping toward. In 2025 strategic buyers made up 52.4% of industrials deal flow against 47.6% for financial sponsors, a sponsor share Capstone describes as the highest on its record. Closed deal volume in industrials fell 24.6% versus 2024.

That table is the most useful thing on this page. The genuine, sourced gap is between roughly 7.2x for sponsor-only deals across all industries and 8.9x for industrials with both buyer types in the mix. It is a real spread and it points the same direction the folklore does. It is simply smaller than advertised, and it is currently shrinking rather than growing.

The mechanism behind the spread is not generosity. A sponsor underwrites your standalone cash flow and a return on the equity it commits, so its ceiling is what the business supports roughly as it runs today. A strategic acquirer can delete duplicate overhead, push your parts through its own sales channel, absorb your volume into a plant running below capacity, or buy your certifications to reach a customer it currently cannot quote. That is value a sponsor structurally cannot pay for. Our guide to strategic buyers versus private equity buyers works through how the two underwrite differently.

The practical consequence is process design. With strategics at 52.4% of industrials deal flow, a sale process that only calls sponsors is ignoring the majority of the buyer pool by count and the half that can pay for synergies. Reaching competitors, adjacent suppliers, and larger platforms already operating in your certified category puts both types in the same room. An unsolicited offer, almost by definition, arrives from one side only.

The Size Ladder Is Real Even Though It Is Not Sector-Specific

Strip the manufacturing label off the CapitalPad restatement of the GF Data ladder and it still earns its place, because size is the dominant variable inside the sponsor universe regardless of what you make. These are year-to-date figures through September 30, 2025, and they are all-industry.

The step from the first band to the second is 0.7 turns. From the second to the third it is 2.1 turns. That jump above $50 million is where a business stops being a bolt-on candidate and becomes a platform a fund can build around, which changes both who bids and how hard. It is also roughly where the fixed cost of serious diligence stops deterring the buyer.

Read it as a ladder you can climb rather than a grade you receive. A manufacturer at $4 million of EBITDA that adds a second certified capability and reaches $8 million has not merely doubled the earnings a multiple applies to. It has plausibly moved up a band, and the two effects compound. Our guide to EBITDA and business valuation basics covers how those brackets work across industries.

Cash EBITDA: The Number a Manufacturing Buyer Actually Models

This is the most important idea in this article and the one most likely to change what you do next.

Reported EBITDA adds back depreciation on the theory that depreciation is a non-cash entry. For a consulting firm with three laptops and a lease, fine. For a plant it is close to a fiction. Depreciation exists precisely to spread the real cash cost of equipment across the years that equipment produces. The press wears out. The spindle wears out. The roof, the compressor, the paint line, the fork trucks: all of it wears out, and none of that spending is optional if you intend to keep shipping. Reported EBITDA adds the cost back and then falls silent about it.

Cash EBITDA is the correction. It is reported EBITDA minus a normalized multi-year average of maintenance capital expenditure — the capital required to keep existing capacity running, as opposed to growth capex that adds capacity you did not have. Use a three-year average. Maintenance capex is lumpy by nature, and a single year containing a major rebuild distorts a one-year read badly in either direction.

Worked Example One: What “6x” Really Costs

A plant does $3 million of EBITDA. Maintenance capex has averaged $600,000 a year over three years. Cash EBITDA is $2.4 million.

A buyer offers 6x. Applied to reported EBITDA that is an $18 million enterprise value, and the term sheet will say 6.0x EBITDA because that is literally true. Now divide the same $18 million by the $2.4 million the business generates after keeping itself running. The buyer is paying 7.5x cash EBITDA. Had the buyer applied 6x to cash EBITDA instead, the price would have been $14.4 million. The gap between those two ways of saying “6x” is $3.6 million.

Nobody has to be acting in bad faith for this to happen. It is what occurs when a multiple lands on the wrong denominator and no one says so out loud.

Worked Example Two: Two Plants, One Price, Two Very Different Deals

Now hold the headline constant and vary the plant. Two businesses each report $5 million of EBITDA on $45 million of revenue. Each receives an offer of $27.5 million, which both sides describe as 5.5x.

The first is a machine shop whose maintenance capex has averaged 4% of revenue, or $1.8 million. Cash EBITDA is $3.2 million. The $27.5 million price is 8.6x cash EBITDA.

The second is a stamping operation running heavy presses at 7% of revenue, or $3.15 million of maintenance capex. Cash EBITDA is $1.85 million. The identical $27.5 million is 14.9x cash EBITDA.

Same sector, same reported earnings, same headline multiple, and one buyer is paying nearly twice what the other is in the only currency that matters. If you own the second business, that spread is your argument for why the price has to move. If you own the first, it is the reason your process should surface a buyer who has done the math.

The Sensitivity, Laid Out

Here is the same exercise across the published spread of manufacturing maintenance capex. Revenue holds at $30 million and reported EBITDA at $3 million in every row. The headline price holds at $18 million, which is 6x reported. Only capex intensity moves.

The bottom row is not a stunt. Nine percent of revenue sits inside the published range for injection molding, and a business spending $2.7 million a year to stand still on $3 million of reported EBITDA throws off roughly $300,000 of genuinely free cash. No competent buyer pays $18 million for that. Which is the point: the headline multiple was never the thing being negotiated.

Run this on your own numbers before someone runs it on you. A private equity buyer builds it into their model in the first week of diligence, and a well-advised strategic does too. Our guide to quality of earnings reports covers how a diligence team formalizes capex normalization, and our EBITDA basics guide covers the wider set of add-backs tested alongside it.

What Maintenance Capex Actually Runs by Process

The figures below are the most granular public breakdown we found, published by CT Acquisitions. They come from a brokerage marketing page rather than a survey, and we flag that every time we use this source.

Two observations. The aerospace line carries a separate tooling load on top of the base range, and that distinction is real: fixturing and tooling for a qualified part number is capital you spend to hold a position you already have, which makes it maintenance rather than growth. Second, the categories with the highest published multiples are frequently the categories with the highest capex intensity. Medical device contract manufacturing sits at the top of both lists. A buyer paying 10x for a business consuming 10% of revenue in maintenance capex has priced that trade deliberately. An owner reading only the multiple column has not.

Use this as a comparison, not a verdict. Pull your own three-year maintenance capex, divide by revenue, and see where you land. If you sit above your process range, have the reason ready. Deferred replacement that produced a catch-up year is a different story from a genuinely capital-hungry process, and either beats a shrug.

The Tax Story Underneath the Capex Line

Capex intensity is not only a cash question. It is also why a manufacturer's book earnings and taxable income can diverge sharply, and a buyer will model both.

Under IRS Publication 946, the maximum Section 179 expense deduction is $2,500,000, reduced dollar for dollar once section 179 property placed in service during the tax year exceeds $4,000,000. Separately, the special depreciation allowance was reinstated at 100% of depreciable basis for qualified property acquired after January 19, 2025, with an election available to claim 40% instead, and a 100% allowance applies to qualified production property placed in service after July 4, 2025 where construction began or acquisition occurred after January 19, 2025.

For an owner the practical effect is that heavy equipment spending can push taxable income far below economic earnings in the years you buy. That is the policy working as designed. It becomes a diligence issue in two ways. A buyer normalizing your earnings will not treat an accelerated deduction as a permanent change in profitability, so your adjusted EBITDA presentation has to be clean about it. And a buyer modeling post-close cash taxes cares a great deal whether you have already consumed the depreciation on the assets they are acquiring, because the tax shield they inherit is smaller than a fresh purchase would generate. Neither point moves the multiple. Both move the cash a buyer projects, and buyers pay out of projected cash.

Machine Age, Remaining Life, and the Appraisal That Sets Your Buyer's Debt

Maintenance capex tells a buyer what you have been spending. It says nothing about what is left.

A plant can post a tidy five-year capex average while sitting on a fleet where six of eight machining centers cross out of useful life within three years. The historical percentage looks identical to a business with a steady replacement cadence. The forward cash requirement does not. CT Acquisitions puts the marker at a fleet averaging under ten years old with 70% or better utilization to command platform pricing, and describes owners with deferred capex seeing one to two turns of compression while owners who can document a clean five-year capex history and a written replacement plan protect the multiple. Treat those turn figures as broker commentary rather than measured outcomes. Treat the logic as sound, because every buyer applies it.

Here is the part owners rarely see coming. Equipment condition does not only shape what a buyer thinks your business is worth. It determines how much they can borrow to buy it, and financing capacity often binds the price more tightly than their view of value does.

Orderly Liquidation Value Versus Fair Market Value in Continued Use

Machinery gets appraised on more than one standard, and the gap between them is wide.

Fair market value in continued use assumes the equipment stays where it is, installed and running as part of a going concern — the power drops, the fixturing, the programs, and the people all still around it. Orderly liquidation value assumes it comes out of the building and sells over a reasonable marketing period with none of that. The same CNC cell appraises at a substantially higher number on the continued-use standard than on the liquidation standard, and for well-maintained late-model equipment the orderly liquidation value can still land well below what the machine cost.

Lenders advance against the lower number, because the lower number is what they can actually recover. That is the whole reason the distinction matters to you. In the SBA-backed lending that finances a meaningful share of lower middle market acquisitions, origination and collateral requirements are governed by SBA SOP 50 10, currently version 8 with an effective date of June 1, 2025, covering the 7(a) and 504 programs. Lender-facing summaries describe used machinery being credited at a materially higher share of value when supported by an orderly liquidation appraisal than without one. We could not retrieve those specific advance-rate percentages from a primary SBA page, so we are not quoting a number we could not open. The direction is not in doubt: an independent appraisal from a qualified appraiser who has walked your floor generally expands what a buyer can finance, and a buyer who can finance more can bid more.

Two practical moves follow. Keep an asset register a third party can audit, with acquisition dates, hours or cycles, and major rebuild history. And if your equipment is genuinely in good condition, consider commissioning an appraisal before you go to market rather than waiting for a lender to order one under time pressure. A favorable appraisal sitting in the data room is a financing argument you control.

Certifications Are Gates. That Is the Entire Mechanism.

Certified categories carry higher published multiples than uncertified ones. Everyone notices the correlation. Fewer people state the mechanism, and the mechanism is what tells you whether chasing a certification is worth the money.

A certification is not a quality signal that flatters a buyer. It is a gate determining which work you are permitted to quote. Your customer cannot buy the part from an uncertified shop even if that shop could hold the tolerance, and requalifying a replacement supplier costs your customer real time and real money: a supplier audit, first article inspection, a validation run, and in regulated categories a filing tied to the specific approved source. That cost sits on your customer, not on you. It is what makes your earnings durable, and durable earnings are what a multiple is supposed to price.

AS9100 and Nadcap: Aerospace, Defense, and Space

AS9100 is the aerospace quality management standard built on ISO 9001. For special processes the relevant accreditation is Nadcap. According to the Performance Review Institute, which administers the program, Nadcap is an industry-managed program serving the aviation, defense, and space sectors, with governance and audit criteria owned and directed by industry subscribers rather than by a standards body, covering 24 critical process accreditations including heat treating, nondestructive testing, welding, chemical processing, and composites, with more than 60 subscribing OEMs. The program dates to 1990.

Read that governance structure carefully, because it explains the premium better than any multiple table can. The primes themselves own the audit criteria. A Nadcap accreditation in heat treating is not a certificate you purchased. It is the primes collectively agreeing you may perform that process on their parts. Losing it removes you from the supply chain. Earning it puts a competitor through the same gate you already cleared.

ISO 13485 and Medical Device Work

Medical device manufacturing carries the highest published ranges in the sub-sector table below and the heaviest ongoing compliance burden to match. ISO 13485 requires a maintained quality management system with documented design controls and an audit history that survives both customer supplier-qualification and regulatory inspection. For Class III implantable devices the customer's own premarket approval pathway is the most rigorous the FDA operates, which pushes supplier requalification from a months-long exercise toward a multi-year one. That is the switching cost, and it is why the category prices where it does. We were unable to retrieve an FDA page to cite directly for the current quality system rules, so we have described the mechanism without attaching regulatory dates we could not verify.

ITAR Registration: A Gate With a Published Price

ITAR registration is the clearest case of a certification working as an access gate, because the requirement is written into federal regulation. Under 22 CFR 122.1, any person who engages in the United States in the business of manufacturing or exporting or temporarily importing defense articles, or furnishing defense services, is required to register with the Directorate of Defense Trade Controls, and registration is generally a precondition to the issuance of any license or other approval under that subchapter.

The fees are published too. 22 CFR 122.3 sets a Tier 1 fee of $3,000 per year for new registrants and for renewing registrants who received no favorable licensing determination in the relevant twelve-month window, $4,000 for renewing registrants with five or fewer favorable determinations, and $4,000 plus $1,100 for each favorable determination above five.

Notice what that schedule reveals. Registration is inexpensive relative to any deal in this market. The barrier was never the fee. It is the compliance infrastructure, the personnel screening, the technical data controls, and a record of operating under them without incident — none of which a competitor assembles in a quarter. It also introduces a diligence dimension that catches owners off guard: a foreign-controlled buyer changes the analysis entirely, and an ITAR-registered manufacturer has a narrower buyer universe than an identical shop without defense work. In a process, that can cut against you.

IATF 16949 and Automotive

Automotive suppliers work to IATF 16949, which layers automotive-specific requirements onto ISO 9001 and gates participation in OEM and tier-one supply chains the way AS9100 gates aerospace. We have not found a public dataset isolating what IATF 16949 is worth in turns of EBITDA, and we will not estimate one. The mechanism matches the categories above. The premium is not something we can size for you from published data.

Sub-Sector Ranges, With the Source Caveat Repeated

These are broker-published ranges from CT Acquisitions. We re-fetched the page for this update and corrected several figures that had drifted in our earlier version, which is itself a reason to treat marketing-page data as provisional.

Source: CT Acquisitions. A note on what we removed. An earlier version of this article carried specialty food, bakery, prepared food, and premium beverage rows attributed to this source. Those categories are not on the page. We have taken them out rather than leave figures standing that we cannot point to. If you manufacture food or beverage products, the table above is not your reference set, and we would rather say so than let you use it.

The pattern inside the table is consistent with everything above. Certified categories sit higher than uncertified ones running comparable equipment. Every category steps up once EBITDA clears a threshold, usually between $10 million and $25 million, which is the same platform-versus-bolt-on line visible in the size ladder. Stamping, fabrication, and injection molding cluster at the bottom, and they are precisely the categories without an industry-standard gate controlling who may quote the work.

Customer Concentration in Manufacturing: The Thresholds and the Paperwork

We corrected this section too, and the correction matters because our earlier framing was more alarming than the source supports.

CT Acquisitions' published thresholds run as follows. Under 15% from a single customer is treated as broadly diversified and earns no discount. From 15% to 25% is acknowledged but rarely repriced. From 25% to 40% triggers a 0.5 to 1.5 turn multiple discount and conversations about earnouts or escrow. Top-three customers above 40% of revenue triggers material discounting. Note the unit. The discount is expressed in turns of EBITDA rather than as a percentage haircut on the multiple, and turns are the currency buyers actually speak in.

It is worth seeing what concentration looks like in a business that has to disclose it. In its fiscal 2025 annual report on Form 10-K, the electronics manufacturing services company Kimball Electronics reported that Nexteer Automotive accounted for 19% of net sales and ZF for 11%, with sales by industry running 49% automotive, 27% medical, and 24% industrial. The filing states plainly that “the nature of the contract manufacturing business is such that start-up of new programs to replace expiring programs occurs frequently,” and lists significant declines in purchases by key customers among its risk factors. A public company with audited financials, a diversified end-market mix, and professional management still carries 30% of revenue in two relationships. That is the category norm rather than a failure, and it is why buyers price concentration as a discount to be sized rather than a disqualification.

A Long-Term Agreement and a Blanket Purchase Order Are Not the Same Instrument

Owners frequently tell us their largest relationship is contracted. When diligence opens the document, it is often a blanket purchase order: a negotiated price, agreed lead times, an annual estimate of quantities, and no binding volume commitment. The customer releases against it when they want parts, and is free to release nothing at all.

A genuine long-term agreement obligates the customer to something. It has a term. It may carry minimum volumes, a requirements commitment, exclusivity for a part number or a program, price adjustment mechanics, and termination provisions with notice periods and wind-down obligations. A buyer's counsel reads for exactly those features and discounts everything else to what it is actually worth, which is the strength of the relationship rather than the strength of the paper.

That distinction changes your preparation. If you hold real long-term agreements, get them organized, current, and assignable, and check the change-of-control language early, because an agreement that terminates on a change of control is a problem you want to find months before a buyer does. If what you hold is blanket purchase orders, do not present them as contracts. Present the honest durability case instead: qualification history, sole-source or dual-source status by part number, tooling you own or hold, program life remaining, and the requalification cost your customer would face. That argument is credible. Overselling a blanket purchase order as a contract is not, and being caught at it damages every other representation you make.

Concentration in manufacturing carries an asymmetry as well. The same qualification barrier that protects you while a relationship holds means there is rarely another qualified customer waiting to absorb your capacity if it ends. In aerospace or medical work, backfilling a lost program can take a year or more. Buyers know it, and it is part of why the discount runs where it does. Our guide to what buyers look for in an acquisition target covers how concentration gets priced across the lower middle market generally.

Raw Material Pass-Through, PPV, and Why Buyers Price Your Commodity Exposure

Ask a buyer what worries them about a fabricator and material cost will be in the first three answers.

The question is not whether your input costs move. They move. The question is who absorbs the movement, and the answer lives in your customer agreements rather than your financial statements. A supply agreement with an indexed material clause tied to a published index on a defined reset cadence transfers commodity risk to your customer. Firm fixed pricing for twelve months on a steel-intensive part keeps that risk squarely with you.

Buyers test this directly, and they test it through purchase price variance. PPV is the gap between the standard cost you set for a material and what you actually paid. Persistent unfavorable PPV that never reaches your customers is a margin leak with a traceable mechanism, and a diligence team will follow it back to the specific agreements that failed to pass it through. Persistent favorable PPV can be its own flag, because it sometimes means your standards are stale rather than your purchasing excellent.

Tariff exposure gets underwritten the same way, and it is usually a question about your bill of materials rather than your finished goods. A domestic manufacturer buying imported raw material, tooling, or components carries tariff risk on the input side even while the reshoring narrative casts it as an output-side winner. Expect a buyer to ask for material origin by spend, which agreements permit a tariff surcharge, and whether you have actually invoked those clauses.

A documented history of passing material moves through, with the contract language that allowed it, is a genuine strength. Present it with the documents attached.

Inventory: Where the Working Capital Peg Fight Actually Happens

In manufacturing, the working capital negotiation is an inventory negotiation wearing a different name.

Every deal with a working capital peg sets a target level of net working capital to be delivered at closing, with a dollar-for-dollar adjustment above or below. Receivables and payables are relatively easy to agree. Inventory is where it gets contested, because inventory carries three judgment calls a buyer and a seller will not naturally answer the same way. Our guide to how the working capital peg works in an M&A deal covers the mechanics in full. What follows is the manufacturing-specific version.

Cost flow method. IRS Publication 538 describes FIFO as assuming the items purchased or produced first are the first sold or otherwise disposed of, and LIFO as assuming the items purchased or produced last are the first sold. Adopting LIFO requires filing Form 970 with a timely filed return for the first year of use, and changing an inventory accounting method requires Form 3115. Where costs are rising, LIFO suppresses reported inventory carrying value and reported income relative to FIFO, which means a LIFO reserve can sit between your balance sheet and the economic value of what is on your floor. A buyer will normalize for it. Know the size of that reserve before they tell you.

Obsolete and slow-moving reserves. This is the most common flashpoint. Manufacturers accumulate raw material for programs that ended, work in process for parts nobody has released against in two years, and finished goods for a customer who redesigned around you. If your reserve policy is thin, your inventory balance is overstated, your historical cost of goods sold is understated, and both your EBITDA and your peg are wrong in the direction the buyer will happily argue about. A quality of earnings provider will age the inventory and propose a reserve. The version proposed under time pressure late in diligence is rarely the version that favors you.

Physical accuracy. Cycle count discipline and the accuracy of your standard costs determine whether anyone can trust the number at all. A plant that has not counted in eighteen months is asking a buyer to accept an estimate as a closing adjustment.

The preparation is unglamorous and it works. Age your inventory now, take the reserve you actually owe, make your cycle counting credible, and be ready to explain your standard cost roll. You will then negotiate the peg from your own numbers instead of from a diligence provider's corrections.

Environmental Diligence: Phase I, Phase II, and the Finding That Stops a Deal

Environmental exposure is a different species of risk from everything else here. It does not usually reprice a deal. It can end one.

Almost every manufacturing transaction involving real property includes a Phase I Environmental Site Assessment: a records and reconnaissance exercise covering title and land use history, regulatory database review, a site walk, and interviews, with no sampling. According to the EPA's All Appropriate Inquiries guidance, ASTM International Standard E1527-21 satisfies the AAI requirements, and every Phase I conducted with EPA Brownfields Assessment Grant funds must comply with the AAI Final Rule at 40 CFR Part 312.

Buyers do this for liability reasons rather than as diligence theater. EPA describes AAI as the basis for the CERCLA liability protections available to innocent landowners who did not know and had no reason to know that hazardous substances had been disposed of at a property, to bona fide prospective purchasers who may buy with knowledge of contamination provided they bought after January 11, 2002 and meet the statutory criteria, and to contiguous property owners. Skip the Phase I and the buyer forfeits the defense. No lender permits it.

A Phase I that identifies a recognized environmental condition triggers a Phase II, which means actual sampling: soil borings, groundwater monitoring wells, sometimes soil vapor. Now you are in a different conversation, and it is worth being honest about how those go. A Phase II finding introduces a liability with no reliable ceiling until it is characterized, and characterization takes months. Buyers respond in a narrow set of ways. They walk. They demand a specific indemnity backed by an escrow or holdback sized to a remediation estimate, which means proceeds tied up for years rather than the customary twelve to eighteen months. They require environmental insurance at your cost. Or they restructure toward an asset purchase engineered to leave the liability behind, which works less cleanly than buyers hope but changes the negotiation.

Holdback mechanics are the same machinery as any other escrow, and our guide to working capital pegs and post-closing adjustments covers how those accounts get funded, released, and fought over.

The preparation advice is simple and widely ignored. If your site has any history that would concern you — degreasing operations, underground tanks, a plating line, a prior industrial tenant — commission your own Phase I before you go to market. Finding a problem on your own schedule with time to characterize and possibly resolve it is a manageable event. Finding it in week six of exclusivity is not.

Union Status and the Liability That Can Exceed the Purchase Price

One item on this list can generate a number larger than what you are selling the business for, and owners are routinely unaware of it until diligence.

A collective bargaining agreement by itself is a known quantity. Buyers underwrite the wage and benefit structure, the term remaining, the grievance history, and successorship obligations, and plenty of unionized manufacturers sell perfectly well. Multiemployer pension participation is a different matter entirely.

Under 29 U.S.C. § 1381, when an employer withdraws from a multiemployer plan in a complete or partial withdrawal, it becomes liable for the allocable amount of the plan's unfunded vested benefits as determined under the statute, subject to various adjustments. Read that as written. The liability is a share of a plan's underfunding. It bears no relationship to the size of your company, your profitability, or what your business is worth, which is why for a small contributing employer to a badly underfunded plan the assessment can exceed enterprise value.

There is a well-worn path through it, and knowing the shape of that path matters before you assume a deal is impossible. 29 U.S.C. § 1384 provides that a bona fide arm's-length sale of assets to an unrelated party is not treated as a withdrawal where three conditions are met. The purchaser takes on an obligation to contribute to the plan for substantially the same number of contribution base units the seller had. The purchaser provides the plan a corporate surety bond or escrow for five plan years, in an amount equal to the greater of the average annual contribution over the preceding three years or the last year's contribution. And the sale contract provides that the seller is secondarily liable for the withdrawal liability it would otherwise have had, should the purchaser fail to pay.

Look hard at that third condition. The seller stays secondarily liable for five years. A structure that clears the withdrawal event does not fully clear you, and how that residual exposure gets papered, indemnified, or secured is a genuine negotiation rather than a formality.

If you contribute to a multiemployer plan, request an estimate of withdrawal liability from the plan before you engage an advisor. Not during diligence. Before. It is the single piece of information most likely to determine whether a sale is feasible and on what structure, and it takes time to obtain.

Owned Real Estate and Rent Normalization

A large share of the manufacturers we speak with own their building, usually through a separate entity from the operating company.

We have not found data supporting the idea that owning your facility raises the multiple on the operating business, and we would be suspicious of a source claiming it. The two assets get priced separately. Where ownership genuinely moves your outcome is through rent normalization, and that arithmetic is worth doing yourself.

If your operating company pays your real estate entity nothing, or pays a rent set for tax reasons rather than market reasons, a buyer will impute market rent before applying any multiple. Say your plant would rent for $400,000 a year and you have been charging the operating company $150,000. The buyer deducts the $250,000 difference from EBITDA. At 6x, that adjustment removes $1.5 million of enterprise value before anyone discusses the building itself. The reverse holds too: an above-market related-party rent is an add-back that raises EBITDA, and buyers accept it when the market comparison is documented.

So the real question is not whether ownership adds a premium. It is how the two pieces get structured. Selling the real estate to the buyer, retaining it and signing an arm's-length lease at a rent you have justified, or running a sale-leaseback alongside the transaction all produce different total proceeds and different tax outcomes. Get a broker's opinion of market rent early, because that one number is doing more work in your valuation than the ownership question ever will.

Where the Manufacturing Cycle Sits Right Now

Buyers underwrite your business inside a macro picture. These are the primary series a diligence team actually watches.

Capacity utilization. The Federal Reserve's G.17 release reports that capacity utilization for manufacturing edged down 0.1 percentage point to 75.7 percent in June, which is 2.5 percentage points below its long-run 1972 to 2025 average, with total industry utilization unchanged at 76.1 percent and 3.3 percentage points below its own long-run average. Slack in the system matters to your deal in a specific way. A strategic acquirer with underused capacity has a stronger synergy case for absorbing your volume, and a weaker case for paying you to keep a second plant running.

Orders and backlog. The Census Bureau's advance report on durable goods manufacturers' shipments, inventories and orders for June 2026, released July 27, 2026, put new orders for manufactured durable goods at $334.8 billion, up 0.3 percent and higher in three of the last four months, following a 4.0 percent May decline. Shipments rose 0.7 percent to $330.7 billion and have increased in nine of the last ten months. Unfilled orders rose 0.6 percent to $1,590.1 billion and have increased in twenty-three of the last twenty-four months. Inventories rose 0.3 percent to $602.0 billion, a ninth consecutive monthly increase. Nondefense new orders for capital goods rose 1.2 percent to $97.8 billion.

The unfilled orders series is the one to sit with. Twenty-three increases in twenty-four months is backlog accumulating across the sector, and backlog is the closest thing a manufacturer has to contracted revenue. If your own backlog has built on the same trend, that is a documentable argument for your management presentation rather than an assertion about market conditions.

Sentiment. The Institute for Supply Management reported a Manufacturing PMI of 53.3 percent for June 2026, with New Orders at 56 percent, Production at 52.2 percent, Employment at 49.7 percent, and Prices at 73 percent, in the report issued by ISM. A reading above 50 percent indicates the manufacturing economy is generally expanding, and ISM notes that a PMI above 47.5 percent over a period of time generally indicates expansion of the overall economy. Two details deserve pulling out. Employment below 50 while new orders sit at 56 describes a sector absorbing more work without adding heads. A Prices index at 73 describes real input cost pressure, which loops straight back to the pass-through question above.

One caution on all three. They describe the sector, not your company, and no buyer pays you more because industrial production sits where it does. They set the frame a buyer reads your numbers against. For structural context on the underlying data, the Census Bureau's Annual Survey of Manufactures has transitioned into the Annual Integrated Economic Survey, with 2022 the most recent benchmark year published.

Do Tariffs and Reshoring Move the Multiple?

Our answer has changed since the last version of this article, and it changed against the narrative.

The reshoring story is usually told as a repricing: supply chains coming home, domestic capacity scarce, multiples rising. Capstone's industrials data does not show that. Multiples went to 8.9x in 2025 from 9.3x in 2024, continuing a compression that started after the 11.4x peak in 2022, and closed deal volume fell 24.6% year over year. Fewer deals at lower multiples is not what a demand-driven revaluation looks like.

That does not make reshoring fictional. It means the effect, if it exists, is not visible in industrials transaction pricing, and anyone telling you your multiple is higher because of tariffs is describing a mechanism nobody has measured. We could not find a source isolating tariff or reshoring exposure as a variable and quantifying it in turns of EBITDA. A sentence like “domestic manufacturers with tariff-exposed import competition command a premium of X turns” would be easy to write and impossible to defend the moment a buyer checks.

There is also a version of the story that runs against you, and it gets discussed far less. Tariffs raise input costs for manufacturers importing raw material, components, or tooling. If your bill of materials carries meaningful import content and your customer agreements do not permit a surcharge, tariff policy is a margin risk rather than a tailwind. It shows up in the Prices index sitting at 73 in the ISM survey above. Buyers model both directions.

If reshoring genuinely benefits your business, put it in the data room as documented fact rather than theme: named customers who moved work to you from an offshore source, quoted volume, program start dates. That is evidence. The theme by itself is not, and in a market where industrials multiples are compressing, the theme will not carry a price on its own.

Who This Article Is For

You own a manufacturing business and you want to know where it sits before you talk to anyone. This piece builds on our guide to M&A advisors for manufacturing and industrials, which covers the buyer landscape and the process itself, and goes deeper on valuation mechanics.

Most owners we work with run founder-owned or family-owned companies somewhere between $2 million and $75 million of revenue, generally with at least $500,000 of adjusted EBITDA. Inside that range the size ladder, the cash EBITDA arithmetic, and the certification and concentration mechanics apply directly. Below it, your likely buyer is an individual operator or a small strategic rather than a private equity platform, and the upper half of the sub-sector table is not your market. Treat all of this as calibration rather than appraisal.

How Manufacturing Compares Across the Lower Middle Market

• Against recurring-revenue services. The contrast with managed IT services isolates a specific difference. An MSP trades at a premium substantially because its revenue is contracted and assignable on paper. A manufacturer's customer relationship is often more durable in practice and far weaker on paper, which is the blanket purchase order problem described above. See our MSP valuation multiples guide.
• Against other consolidating sectors. Manufacturing shares the platform-and-bolt-on dynamic with childcare and several service categories. See our childcare and daycare valuation multiples guide and our piece on why roll-ups are heating up.
• Against capital-light businesses. The cash EBITDA gap is largely a capital-intensity phenomenon. A business services company with minimal fixed assets does not face the same divergence between reported and cash earnings. Worth remembering before you benchmark your multiple against a friend's services business, because the two numbers are not adjusted on the same basis.
• On timing. Certification work, capex normalization, an inventory reserve cleanup, and a withdrawal liability estimate are all multi-quarter projects. Our guide on when to start exit planning covers how they sequence, and how a lower middle market sale process unfolds covers what happens once you begin.

Getting a Range Specific to Your Business

The ranges above tell you where manufacturers trade and, more usefully, which of the published numbers are not describing what they appear to describe. They cannot tell you where you land.

A preliminary valuation conversation is how a market range turns into an estimate built on your business. Jack and Connor handle these directly. There is no retainer and no cost to the conversation, and no obligation to sell at the end of it.

If you want more context first, start with our guide to M&A advisors for manufacturing and industrials, then read how Salt Creek approaches business valuation and how a lower middle market sale process actually unfolds.